Millan-Casarrubias, E.J.; GarcÃa-Tejeda, Y.V.; González-De la Rosa, C.H.; Ruiz-Mazón, L.; Hernández-RodrÃguez, Y.M.; Cigarroa-Mayorga, O.E.
Molecular Docking and Pharmacological In Silico Evaluation of Camptothecin and Related Ligands as Promising HER2-Targeted Therapies for Breast Cancer. Curr. Issues Mol. Biol. 2025, 47, 193.
https://doi.org/10.3390/cimb47030193
AMA Style
Millan-Casarrubias EJ, GarcÃa-Tejeda YV, González-De la Rosa CH, Ruiz-Mazón L, Hernández-RodrÃguez YM, Cigarroa-Mayorga OE.
Molecular Docking and Pharmacological In Silico Evaluation of Camptothecin and Related Ligands as Promising HER2-Targeted Therapies for Breast Cancer. Current Issues in Molecular Biology. 2025; 47(3):193.
https://doi.org/10.3390/cimb47030193
Chicago/Turabian Style
Millan-Casarrubias, Elmer Joel, Yunia Verónica GarcÃa-Tejeda, Claudia Haydée González-De la Rosa, Lucero Ruiz-Mazón, YazmÃn Mariela Hernández-RodrÃguez, and Oscar Eduardo Cigarroa-Mayorga.
2025. "Molecular Docking and Pharmacological In Silico Evaluation of Camptothecin and Related Ligands as Promising HER2-Targeted Therapies for Breast Cancer" Current Issues in Molecular Biology 47, no. 3: 193.
https://doi.org/10.3390/cimb47030193
APA Style
Millan-Casarrubias, E. J., GarcÃa-Tejeda, Y. V., González-De la Rosa, C. H., Ruiz-Mazón, L., Hernández-RodrÃguez, Y. M., & Cigarroa-Mayorga, O. E.
(2025). Molecular Docking and Pharmacological In Silico Evaluation of Camptothecin and Related Ligands as Promising HER2-Targeted Therapies for Breast Cancer. Current Issues in Molecular Biology, 47(3), 193.
https://doi.org/10.3390/cimb47030193
